We are live on
!
Find out more
GC
Gratry & Company Portfolio holdings
AUM
$72.2M
1-Year Est. Return
19.87%
This Fund
S&P 500
This Quarter
Est. Return
+3.03%
1 Year Est. Return
+19.87%
3 Year Est. Return
+44.17%
5 Year Est. Return
+89.51%
10 Year Est. Return
–
AUM
$278M
AUM Growth
-$27.6M
(-9%)
Cap. Flow
-$26.4M
Cap. Flow
% of AUM
-9.52%
Top 10 Holdings %
Top 10 Hldgs %
34.89%
Holding
73
New
4
Increased
18
Reduced
38
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pentair
PNR
|
+$7.32M |
| 2 |
AGN
Allergan plc
AGN
|
+$6.81M |
| 3 |
NBIS
Nebius Group N.V.
NBIS
|
+$4.72M |
| 4 |
HIT
HITACHI LTD ADR (10COM)NEW
HIT
|
+$3.49M |
| 5 |
Melco Resorts & Entertainment
MLCO
|
+$3.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ORIX
IX
|
+$8.45M |
| 2 |
SI
SIEMENS AKTIENGESELLSCHAFT ADS
SI
|
+$8.42M |
| 3 |
ESV
Ensco Rowan plc
ESV
|
+$6.83M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
+$6.78M |
| 5 |
BRG
BG GROUP PLC ADS(RP 5 ORD SHS)
BRG
|
+$6.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.94% |
| 2 | Industrials | 13.6% |
| 3 | Financials | 11.96% |
| 4 | Consumer Discretionary | 9.06% |
| 5 | Technology | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
NXP Semiconductors
NXPI
$67.5B
| $13.1M | 4.72% |
222,865
+3,535
| +2% | +$184K |
|
|
CBI
2
DELISTED
Chicago Bridge & Iron Nv
CBI
| $11.7M | 4.22% |
134,578
-6,135
| -4% | -$498K |
|
|
NVO
3
Novo Nordisk
NVO
$219B
| $9.88M | 3.56% |
433,078
-13,512
| -3% | -$288K |
|
|
BAY
4
DELISTED
BAYER AG SPONS ADR
BAY
| $9.24M | 3.33% |
68,316
-1,531
| -2% | -$207K |
|
5
LyondellBasell Industries
LYB
$19.6B
| $9.11M | 3.28% |
102,415
+780
| +0.8% | +$65.6K |
|
6
Eaton
ETN
$156B
| $9.05M | 3.26% |
120,476
-4,405
| -4% | -$325K |
|
7
Aptiv
APTV
$12.1B
| $8.9M | 3.2% |
131,135
-2,160
| -2% | -$138K |
|
8
ING
ING
$92B
| $8.54M | 3.08% |
599,643
-16,197
| -3% | -$228K |
|
9
Novartis
NVS
$285B
| $8.36M | 3.01% |
109,762
-5,972
| -5% | -$435K |
|
10
Chubb
CB
$137B
| $8.33M | 3% |
84,121
-2,020
| -2% | -$196K |
|
|
COV
11
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $8.11M | 2.92% |
110,117
-4,035
| -4% | -$281K |
|
|
DT
12
DELISTED
DEUTSCHE TELEKOM AG ADS (1ORD)
DT
| $7.96M | 2.87% |
490,859
-10,961
| -2% | -$178K |
|
13
Toyota
TM
$211B
| $7.72M | 2.78% |
68,369
-2,064
| -3% | -$238K |
|
|
14
Jazz Pharmaceuticals
JAZZ
$15.3B
| $7.52M | 2.71% |
54,220
-45,053
| -45% | -$6.78M |
|
|
15
Pentair
PNR
$10B
| $7.47M | 2.69% |
+140,152
| New | +$7.32M |
|
|
AZ
16
DELISTED
Allianz Se Sponsored Adr Repstg 1/10 Ord Sh
AZ
| $7.41M | 2.67% |
439,820
-10,275
| -2% | -$173K |
|
|
AGN
17
DELISTED
Allergan plc
AGN
| $7.08M | 2.55% |
+34,395
| New | +$6.81M |
|
|
WX
18
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
| $7.06M | 2.54% |
191,545
-14,255
| -7% | -$523K |
|
|
HIT
19
DELISTED
HITACHI LTD ADR (10COM)NEW
HIT
| $6.67M | 2.4% |
89,721
+46,986
| +110% | +$3.49M |
|
20
Diageo
DEO
$47.2B
| $6.53M | 2.35% |
52,442
-698
| -1% | -$87K |
|
21
National Grid
NGG
$82B
| $6.36M | 2.29% |
95,876
+2,396
| +3% | +$154K |
|
|
22
Melco Resorts & Entertainment
MLCO
$2.13B
| $6.24M | 2.25% |
161,404
+81,779
| +103% | +$3.4M |
|
23
Sumitomo Mitsui Financial
SMFG
$158B
| $6.24M | 2.25% |
721,020
-56,375
| -7% | -$527K |
|
|
NBIS
24
Nebius Group N.V.
NBIS
$46.4B
| $6.04M | 2.18% |
200,230
+127,870
| +177% | +$4.72M |
|
25
TE Connectivity
TEL
$59.3B
| $5.98M | 2.15% |
99,365
-2,525
| -2% | -$145K |
|
Similar funds
T
DCM
XS
BSCP
SCM
FMA
MSTVIM
LA
Gratry & Company's Q1 2014 Portfolio in Review
As of Q1 2014, Gratry & Company held 73 positions worth $278M, down 9% from $305M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Gratry & Company withdrew a net $26.4M in Q1 2014, closing 10 positions and reducing 38 holdings. Its most notable exit was ORIX, an estimated $8.45M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Industrials and Financials.
Against the trend, Gratry & Company opened a new position in Pentair worth $7.47M.
- Gratry & Company's largest Q1 2014 buy was Pentair: 140,152 shares worth $7.47M.
- Gratry & Company added most to Nebius Group N.V. in Q1 2014, an estimated $4.72M increase.
- Gratry & Company's biggest Q1 2014 reduction was Jazz Pharmaceuticals, cutting an estimated $6.78M.
- Gratry & Company fully exited ORIX in Q1 2014, selling an estimated $8.45M.
- Gratry & Company's ten largest holdings make up 35% of its $278M portfolio in Q1 2014.
- Gratry & Company opened 4 new positions and closed 10 in Q1 2014.
- Gratry & Company's portfolio value fell 9% quarter-over-quarter to $278M.
Based on Gratry & Company's 13F filing for Q1 2014, filed 20 May 2014.